Twin Tree Management
ABBV icon

Twin Tree Management’s AbbVie ABBV Stock Holding History

Twin Tree Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-305,300
Closed -$70.7M – 1353
2025
Q3 		$70.7M Sell
305,300
-242,300
-44% -$49.3M 0.29% 53
2025
Q2 		$102M Sell
547,600
-163,900
-23% -$30.5M 0.19% 89
2025
Q1 		$149M Buy
711,500
+414,900
+140% +$80.7M 0.28% 42
2024
Q4 		$52.7M Buy
296,600
+89,200
+43% +$16.4M 0.09% 185
2024
Q3 		$41M Buy
207,400
+5,600
+3% +$1.05M 0.08% 207
2024
Q2 		$34.6M Buy
201,800
+100,900
+100% +$16.7M 0.08% 229
2024
Q1 		$18.4M Sell
100,900
-1,737,800
-95% -$299M 0.04% 432
2023
Q4 		$285M Sell
1,838,700
-134,100
-7% -$19.6M 0.54% 25
2023
Q3 		$294M Buy
1,972,800
+556,100
+39% +$81.6M 0.66% 15
2023
Q2 		$191M Buy
1,416,700
+1,137,300
+407% +$167M 0.29% 58
2023
Q1 		$44.5M Buy
279,400
+32,100
+13% +$4.91M 0.08% 204
2022
Q4 		$40M Sell
247,300
-81,500
-25% -$12.5M 0.09% 210
2022
Q3 		$44.1M Sell
328,800
-198,400
-38% -$28.5M 0.08% 192
2022
Q2 		$80.7M Buy
527,200
+275,500
+109% +$42.1M 0.13% 107
2022
Q1 		$40.8M Buy
251,700
+93,100
+59% +$13.5M 0.07% 247
2021
Q4 		$21.5M Sell
158,600
-243,900
-61% -$28.8M 0.04% 386
2021
Q3 		$43.4M Sell
402,500
-92,800
-19% -$10.6M 0.1% 197
2021
Q2 		$55.8M Buy
495,300
+445,200
+889% +$50.1M 0.15% 137
2021
Q1 		$5.42M Buy
+50,100
New +$5.36M 0.02% 627
2020
Q3 		– Sell
-203,400
Closed -$20M – 1179
2020
Q2 		$20M Buy
203,400
+109,500
+117% +$9.64M 0.08% 279
2020
Q1 		$7.15M Sell
93,900
-460,700
-83% -$39.2M 0.03% 405
2019
Q4 		$49.1M Buy
554,600
+102,100
+23% +$8.48M 0.17% 96
2019
Q3 		$34.3M Buy
452,500
+191,400
+73% +$13.1M 0.14% 123
2019
Q2 		$19M Sell
261,100
-535,600
-67% -$42.1M 0.09% 192
2019
Q1 		$64.2M Buy
796,700
+501,800
+170% +$41.1M 0.33% 61
2018
Q4 		$27.2M Buy
294,900
+50,400
+21% +$4.43M 0.17% 106
2018
Q3 		$23.1M Sell
244,500
-91,200
-27% -$8.65M 0.16% 121
2018
Q2 		$31.1M Buy
335,700
+209,500
+166% +$20.5M 0.19% 99
2018
Q1 		$11.9M Buy
+126,200
New +$13.9M 0.1% 177
2017
Q4 		– Sell
-38,700
Closed -$3.44M – 985
2017
Q3 		$3.44M Sell
38,700
-266,400
-87% -$20.3M 0.03% 468
2017
Q2 		$22.1M Sell
305,100
-360,900
-54% -$24.3M 0.17% 124
2017
Q1 		$43.4M Buy
666,000
+134,600
+25% +$8.46M 0.39% 45
2016
Q4 		$33.3M Buy
531,400
+390,500
+277% +$23.8M 0.33% 51
2016
Q3 		$8.89M Sell
140,900
-6,700
-5% -$434K 0.11% 180
2016
Q2 		$9.14M Sell
147,600
-72,300
-33% -$4.41M 0.14% 156
2016
Q1 		$12.6M Buy
219,900
+73,900
+51% +$4.12M 0.24% 81
2015
Q4 		$8.65M Buy
146,000
+126,400
+645% +$7.28M 0.17% 111
2015
Q3 		$1.07M Sell
19,600
-27,600
-58% -$1.8M 0.03% 523
2015
Q2 		$3.17M Buy
+47,200
New +$3.08M 0.08% 256

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Twin Tree Management's ABBV Position: Q2 2024 in Review

Twin Tree Management sold out of AbbVie (ABBV) in Q2 2024, closing a stake of 17,753 shares — an estimated $2.94M sold.

Twin Tree Management first reported a position in ABBV in Q2 2013 and held it in 16 quarters. The position peaked at $22.1M in Q1 2022. 3,364 funds tracked by Wall St. Rank hold ABBV as of Q2 2024.

  • Twin Tree Management reported no remaining AbbVie position as of Q2 2024 after selling out during the quarter.
  • Twin Tree Management sold 17,753 AbbVie shares in Q2 2024, an estimated $2.94M.
  • Twin Tree Management first reported a position in AbbVie in Q2 2013 and held it in 16 quarters.
  • Twin Tree Management's AbbVie position peaked at $22.1M in Q1 2022.
  • 3,364 funds tracked by Wall St. Rank held AbbVie as of Q2 2024.

Based on Twin Tree Management's 13F filing for Q2 2024, filed 13 Aug 2024.